Current Fiscal Year Data

In 1984 a group of distinguished trustees appointed by the Delaware Court of Chancery assumed responsibility for the Institute and reaffirmed its primary purpose of basic medical research. They guided the Institute through the sale of the Hughes Aircraft Company on December 20, 1985, creating the endowment that is its principal source of funding. This reorganization and sale of Hughes Aircraft marks the beginning of the modern era of Institute activities, and serves as the starting point for the presentation of cumulative expenditure information.

At the end of fiscal year 2009, the Institute had $13.9 billion in diversified net assets, making it the nation's largest private supporter of academic biomedical research.

		Download the 2009 Audited Financial Statements (264 KB PDF)

Questions or comments about information contained in the Institute's audited financial statements should be directed to Edward J. Palmerino, Vice President for Finance and Treasurer or to Robert C. Mullins, Controller.

	10 Year Snapshot 2000-2009 $6.2 billion Direct support from HHMI for research and science education $5.3 billion Cumulative expenditures for scientific research 76 % Proportion of HHMI expenditures for scientific research (excluding grants and laboratory space) $673 million HHMI's investment in laboratory space $942 million Cumulative expenditures for Grants and Special Programs -14.9 % Annual rate of return on HHMI endowment		Today FY 2009 $14.0 billion Value of HHMI endowment at the end of the year $831 million HHMI disbursements for scientific research, grants, and capital initiatives $730 million HHMI disbursements for scientific research and capital initiatives $101 million HHMI disbursements for grants